Logo image of CTRE

CARETRUST REIT INC (CTRE) Stock Fundamental Analysis

USA - NYSE:CTRE - US14174T1079 - REIT

34.65 USD
+0.3 (+0.87%)
Last: 10/31/2025, 8:04:00 PM
34.65 USD
0 (0%)
After Hours: 10/31/2025, 8:04:00 PM
Fundamental Rating

7

Taking everything into account, CTRE scores 7 out of 10 in our fundamental rating. CTRE was compared to 127 industry peers in the Diversified REITs industry. While CTRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CTRE is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, CTRE could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CTRE was profitable.
In the past year CTRE had a positive cash flow from operations.
Of the past 5 years CTRE 4 years were profitable.
Each year in the past 5 years CTRE had a positive operating cash flow.
CTRE Yearly Net Income VS EBIT VS OCF VS FCFCTRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.71%, CTRE belongs to the top of the industry, outperforming 92.91% of the companies in the same industry.
With a decent Return On Equity value of 6.64%, CTRE is doing good in the industry, outperforming 77.17% of the companies in the same industry.
CTRE's Return On Invested Capital of 4.38% is amongst the best of the industry. CTRE outperforms 83.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CTRE is above the industry average of 3.04%.
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROIC 4.38%
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
CTRE Yearly ROA, ROE, ROICCTRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

CTRE has a better Profit Margin (58.73%) than 97.64% of its industry peers.
In the last couple of years the Profit Margin of CTRE has grown nicely.
CTRE has a Operating Margin of 66.50%. This is amongst the best in the industry. CTRE outperforms 99.21% of its industry peers.
CTRE's Operating Margin has improved in the last couple of years.
CTRE's Gross Margin of 98.44% is amongst the best of the industry. CTRE outperforms 98.43% of its industry peers.
Industry RankSector Rank
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
CTRE Yearly Profit, Operating, Gross MarginsCTRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

CTRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CTRE has more shares outstanding
CTRE has more shares outstanding than it did 5 years ago.
CTRE has a better debt/assets ratio than last year.
CTRE Yearly Shares OutstandingCTRE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTRE Yearly Total Debt VS Total AssetsCTRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CTRE has an Altman-Z score of 3.53. This indicates that CTRE is financially healthy and has little risk of bankruptcy at the moment.
CTRE has a better Altman-Z score (3.53) than 97.64% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that CTRE is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, CTRE belongs to the top of the industry, outperforming 96.06% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 3.53
ROIC/WACC0.52
WACC8.49%
CTRE Yearly LT Debt VS Equity VS FCFCTRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.75 indicates that CTRE should not have too much problems paying its short term obligations.
CTRE has a better Current ratio (1.75) than 75.59% of its industry peers.
A Quick Ratio of 1.75 indicates that CTRE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.75, CTRE is in the better half of the industry, outperforming 75.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
CTRE Yearly Current Assets VS Current LiabilitesCTRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

9

3. Growth

3.1 Past

CTRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 108.47%, which is quite impressive.
Measured over the past years, CTRE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.30% on average per year.
CTRE shows a strong growth in Revenue. In the last year, the Revenue has grown by 50.83%.
The Revenue has been growing by 12.64% on average over the past years. This is quite good.
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%55.27%

3.2 Future

CTRE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.18% yearly.
The Revenue is expected to grow by 27.43% on average over the next years. This is a very strong growth
EPS Next Y77.46%
EPS Next 2Y38.41%
EPS Next 3Y26.18%
EPS Next 5YN/A
Revenue Next Year45.48%
Revenue Next 2Y35.09%
Revenue Next 3Y27.43%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRE Yearly Revenue VS EstimatesCTRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
CTRE Yearly EPS VS EstimatesCTRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 28.17, the valuation of CTRE can be described as expensive.
Based on the Price/Earnings ratio, CTRE is valued a bit cheaper than the industry average as 62.20% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.10, CTRE is valued at the same level.
Based on the Price/Forward Earnings ratio of 22.06, the valuation of CTRE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CTRE is valued cheaply inside the industry as 88.19% of the companies are valued more expensively.
CTRE's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.52.
Industry RankSector Rank
PE 28.17
Fwd PE 22.06
CTRE Price Earnings VS Forward Price EarningsCTRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTRE indicates a rather expensive valuation: CTRE more expensive than 92.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.87
CTRE Per share dataCTRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

CTRE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRE has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CTRE's earnings are expected to grow with 26.18% in the coming years.
PEG (NY)0.36
PEG (5Y)2.49
EPS Next 2Y38.41%
EPS Next 3Y26.18%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.84%, CTRE has a reasonable but not impressive dividend return.
CTRE's Dividend Yield is slightly below the industry average, which is at 6.35.
Compared to an average S&P500 Dividend Yield of 2.35, CTRE pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.84%

5.2 History

The dividend of CTRE has a limited annual growth rate of 4.05%.
CTRE has been paying a dividend for at least 10 years, so it has a reliable track record.
CTRE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.05%
Div Incr Years9
Div Non Decr Years9
CTRE Yearly Dividends per shareCTRE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CTRE pays out 96.62% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CTRE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP96.62%
EPS Next 2Y38.41%
EPS Next 3Y26.18%
CTRE Yearly Income VS Free CF VS DividendCTRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
CTRE Dividend Payout.CTRE Dividend Payout, showing the Payout Ratio.CTRE Dividend Payout.PayoutRetained Earnings

CARETRUST REIT INC

NYSE:CTRE (10/31/2025, 8:04:00 PM)

After market: 34.65 0 (0%)

34.65

+0.3 (+0.87%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners89.46%
Inst Owner Change1.09%
Ins Owners0.47%
Ins Owner Change1.14%
Market Cap7.74B
Revenue(TTM)373.42M
Net Income(TTM)219.30M
Analysts83.75
Price Target37.63 (8.6%)
Short Float %4.13%
Short Ratio4.26
Dividend
Industry RankSector Rank
Dividend Yield 3.84%
Yearly Dividend1.09
Dividend Growth(5Y)4.05%
DP96.62%
Div Incr Years9
Div Non Decr Years9
Ex-Date09-30 2025-09-30 (0.335)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.16%
Min EPS beat(2)-6.76%
Max EPS beat(2)0.43%
EPS beat(4)2
Avg EPS beat(4)-8.38%
Min EPS beat(4)-29.49%
Max EPS beat(4)2.3%
EPS beat(8)2
Avg EPS beat(8)-24.52%
EPS beat(12)2
Avg EPS beat(12)-38.92%
EPS beat(16)4
Avg EPS beat(16)-30.02%
Revenue beat(2)1
Avg Revenue beat(2)-6.12%
Min Revenue beat(2)-15.93%
Max Revenue beat(2)3.69%
Revenue beat(4)2
Avg Revenue beat(4)2.83%
Min Revenue beat(4)-15.93%
Max Revenue beat(4)33.8%
Revenue beat(8)4
Avg Revenue beat(8)1.97%
Revenue beat(12)7
Avg Revenue beat(12)1.67%
Revenue beat(16)8
Avg Revenue beat(16)0.79%
PT rev (1m)2.11%
PT rev (3m)11.04%
EPS NQ rev (1m)0.94%
EPS NQ rev (3m)0.94%
EPS NY rev (1m)1.18%
EPS NY rev (3m)1.91%
Revenue NQ rev (1m)5.1%
Revenue NQ rev (3m)7.73%
Revenue NY rev (1m)3.66%
Revenue NY rev (3m)6.12%
Valuation
Industry RankSector Rank
PE 28.17
Fwd PE 22.06
P/S 20.72
P/FCF N/A
P/OCF 24.59
P/B 2.34
P/tB 2.34
EV/EBITDA 26.87
EPS(TTM)1.23
EY3.55%
EPS(NY)1.57
Fwd EY4.53%
FCF(TTM)-5.04
FCFYN/A
OCF(TTM)1.41
OCFY4.07%
SpS1.67
BVpS14.78
TBVpS14.78
PEG (NY)0.36
PEG (5Y)2.49
Graham Number20.23
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 6.64%
ROCE 5.54%
ROIC 4.38%
ROICexc 4.7%
ROICexgc 4.7%
OM 66.5%
PM (TTM) 58.73%
GM 98.44%
FCFM N/A
ROA(3y)1.9%
ROA(5y)3.08%
ROE(3y)2.37%
ROE(5y)4.75%
ROIC(3y)5.24%
ROIC(5y)5.34%
ROICexc(3y)5.66%
ROICexc(5y)5.62%
ROICexgc(3y)5.66%
ROICexgc(5y)5.62%
ROCE(3y)6.63%
ROCE(5y)6.75%
ROICexgc growth 3Y-3.12%
ROICexgc growth 5Y0.18%
ROICexc growth 3Y-3.12%
ROICexc growth 5Y0.18%
OM growth 3Y5.41%
OM growth 5Y3.45%
PM growth 3Y4.22%
PM growth 5Y8.32%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA 3.64
Cap/Depr 2097.02%
Cap/Sales 385.9%
Interest Coverage 8.55
Cash Conversion 99.23%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 3.53
F-Score5
WACC8.49%
ROIC/WACC0.52
Cap/Depr(3y)658.62%
Cap/Depr(5y)503.99%
Cap/Sales(3y)134.69%
Cap/Sales(5y)112.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.47%
EPS 3Y-1.19%
EPS 5Y11.3%
EPS Q2Q%400%
EPS Next Y77.46%
EPS Next 2Y38.41%
EPS Next 3Y26.18%
EPS Next 5YN/A
Revenue 1Y (TTM)50.83%
Revenue growth 3Y15.48%
Revenue growth 5Y12.64%
Sales Q2Q%55.27%
Revenue Next Year45.48%
Revenue Next 2Y35.09%
Revenue Next 3Y27.43%
Revenue Next 5YN/A
EBIT growth 1Y56.55%
EBIT growth 3Y21.72%
EBIT growth 5Y16.53%
EBIT Next Year182.97%
EBIT Next 3Y56.82%
EBIT Next 5Y39.97%
FCF growth 1Y-2758.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.86%
OCF growth 3Y15.9%
OCF growth 5Y14.1%

CARETRUST REIT INC / CTRE FAQ

What is the fundamental rating for CTRE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CTRE.


What is the valuation status for CTRE stock?

ChartMill assigns a valuation rating of 4 / 10 to CARETRUST REIT INC (CTRE). This can be considered as Fairly Valued.


What is the profitability of CTRE stock?

CARETRUST REIT INC (CTRE) has a profitability rating of 8 / 10.


Can you provide the financial health for CTRE stock?

The financial health rating of CARETRUST REIT INC (CTRE) is 5 / 10.


Can you provide the dividend sustainability for CTRE stock?

The dividend rating of CARETRUST REIT INC (CTRE) is 5 / 10 and the dividend payout ratio is 96.62%.